07:56 AM EDT, 08/07/2024 (MT Newswires) -- Charles River Laboratories International ( CRL ) reported Q2 non-GAAP earnings Wednesday of $2.80 per diluted share, up from $2.69 a year earlier.

Analysts polled by Capital IQ expected $2.39.

Revenue for the quarter ended June 29 was $1.03 billion, compared with $1.06 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.02 billion.

The company reduced its full-year 2024 non-GAAP earnings guidance to $9.90 to $10.20 per share, from $10.90 to $11.40 previously. Analysts polled by Capital IQ expect $10.99.

The company's shares dropped almost 15% during recent premarket activity on Wednesday.

Price: 194.99, Change: -33.81, Percent Change: -14.78